Osteoarthritis has a significant genetic component, though it’s not caused by a single inherited gene. Twin and family studies estimate that genetics account for 40% to 70% of your risk, depending on which joint is affected. The rest comes from factors like body weight, joint injuries, occupation, and age. So while you can inherit a higher susceptibility, your genes don’t seal your fate.
How Much Risk Is Inherited
The genetic contribution to osteoarthritis varies by joint site. Heritability estimates break down roughly as follows: about 40% for the knee, 60% for the hip, 65% for the hand, and around 70% for the spine. These numbers come from twin studies comparing identical twins (who share all their DNA) with fraternal twins (who share about half). When identical twins develop osteoarthritis at higher rates than fraternal twins, the difference points to genetics.
A large Swedish family study put concrete numbers on what this means in practice. If your sibling has knee osteoarthritis, your risk is about 1.75 times higher than someone without an affected sibling. For hip osteoarthritis, it’s roughly double. Thumb osteoarthritis shows an even stronger family link, with siblings facing about 2.6 times the risk. Among twins, these numbers climb higher still: twins of someone with hip osteoarthritis had 3.4 times the risk, and twins of someone with thumb osteoarthritis had over 5 times the risk. These figures hold after adjusting for shared environmental factors like diet and activity level.
It’s Not One Gene, It’s Hundreds
Osteoarthritis is what geneticists call a “complex” or “polygenic” disease. Rather than a single mutation causing the condition, many small genetic variations each nudge your risk up or down slightly. A 2025 genome-wide study published in Nature, covering nearly two million people, identified 962 independent genetic associations across 286 regions of the genome. More than half of those associations were newly discovered, which gives a sense of how much is still being mapped out.
The genes involved tend to cluster around a few key biological processes. Many affect how your body builds and maintains cartilage, the smooth tissue that cushions your joints. Others influence bone growth, inflammation, and how your body repairs tissue after damage.
What These Genes Actually Do in Your Joints
The clearest genetic links involve collagen, the structural protein that gives cartilage its strength and flexibility. Type II collagen is the main building block of joint cartilage, and mutations in the gene that produces it (COL2A1) can weaken cartilage from the start. Mutations in related collagen genes, like those producing types IX and XI collagen, also cause cartilage to assemble improperly. In some cases, the collagen forms but doesn’t cross-link correctly, making it less resilient to the daily compression and friction joints endure.
Another well-studied gene involves a signaling molecule called SMAD3, which helps regulate how cartilage cells behave. Normally, this molecule encourages cartilage cells to produce collagen and protective compounds while suppressing enzymes that break cartilage down. When SMAD3 signaling is disrupted by certain genetic variants, the balance tips: cartilage-degrading enzymes ramp up, and collagen production drops. In people with hip osteoarthritis who carry the risk variant, researchers found higher levels of a cartilage-destroying enzyme and lower levels of type II collagen production.
Genes involved in vitamin D metabolism and bone growth factors also play a role. Some variants affect how efficiently your body can repair micro-damage in cartilage after normal wear, which over decades can mean the difference between joints that hold up and joints that gradually deteriorate.
Epigenetics: Where Genes Meet Environment
Your DNA sequence is only part of the story. Epigenetics, the system that controls which genes are turned on or off, plays a growing role in explaining why some people with genetic risk develop osteoarthritis and others don’t. The most studied mechanism is DNA methylation, a chemical tag that can silence or activate genes without changing the underlying code.
In osteoarthritis, researchers have found that cartilage cells show altered methylation patterns compared to healthy cartilage. For example, one enzyme involved in cartilage breakdown becomes overactive when its gene loses methylation tags that normally keep it quiet. This was especially pronounced in people who already carried a genetic risk variant, suggesting a “double hit” scenario: the genetic variant raises your baseline risk, and changes in methylation push it over the threshold into disease.
Some of these methylation changes reactivate genes that are normally only active during childhood bone growth. In adults, turning these developmental programs back on in joint tissue can trigger cartilage cells to behave abnormally, contributing to the breakdown seen in osteoarthritis. Environmental factors like joint injuries, obesity, and chronic inflammation can all drive these epigenetic changes, which helps explain why osteoarthritis results from an interplay between your inherited risk and your life circumstances.
Nodal Osteoarthritis: The Strongest Genetic Form
One subtype of osteoarthritis has a particularly strong hereditary pattern. Nodal generalized osteoarthritis, which causes bony enlargements at the finger joints (especially the joints closest to your fingertips), runs clearly in families. The clustering of these finger nodes among women in the same family has been recognized for decades. Segregation analyses, including data from the long-running Framingham Heart Study, confirm that heritable factors contribute heavily to this form.
Research suggests that multiple susceptibility genes work together to produce nodal osteoarthritis, and these genes may not act exclusively on the hands. People with nodal osteoarthritis often develop the condition in other joints as well, pointing to a systemic genetic predisposition rather than a hand-specific one.
Can Genetic Testing Predict Your Risk?
Not yet, in any clinically useful way. Despite the hundreds of genetic associations now identified, no genetic test is currently recommended for diagnosing or predicting osteoarthritis. Each individual variant contributes only a tiny amount to overall risk, and the interactions between hundreds of genes, epigenetic changes, and environmental factors are too complex for a simple test to capture meaningfully.
Researchers are working toward combining genomic data into “polygenic risk scores” that could eventually help identify people at high risk before symptoms appear. But for now, the strongest predictors of whether you’ll develop osteoarthritis remain practical ones: family history, joint injuries, body weight, and the physical demands of your work or activities. If osteoarthritis runs in your family, that information alone is more actionable than any genetic test available today, and it’s a reasonable signal to prioritize joint-friendly exercise, maintain a healthy weight, and protect your joints from repeated high-impact stress.